| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.098 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |